M. Margetts

发表

Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis.

J. Mattick, I. Barr, B. Gaëta, 2001, Vaccine.

The signalling conformation of the insulin receptor ectodomain

C. Müller, J. Menting, T. Langer, 2018, Nature Communications.

The signalling conformation of the insulin receptor ectodomain

C. Müller, J. Menting, T. Langer, 2018, Nature Communications.

How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor

J. Menting, M. Lawrence, B. Forbes, 2022, Structure.

Higher-Resolution Structu re of the Human Insulin Receptor Ectodomain : Multi-Modal Inclusion of the Insert Domain Graphical

Brian J. Smith, M. Lawrence, M. Weiss, 2022 .

Characterization and expression of a novel Porphyromonas gingivalis outer membrane protein, Omp28.

I. Barr, N. Slakeski, C. Moore, 2002, Oral microbiology and immunology.

Overexpression, purification, and refolding of a Porphyromonas gingivalis cysteine protease from Escherichia coli.

I. Barr, M. Margetts, E. Webb, 2000, Protein expression and purification.

Activation of the human insulin receptor by non-insulin-related peptides

M. Lawrence, V. Kiselyov, M. Margetts, 2022, Nature Communications.

How insulin engages its primary binding site on the insulin receptor

Andrzej M. Brzozowski, Colin W. Ward, Christopher J. Watson, 2013, Nature.

Structural Congruency of Ligand Binding to the Insulin and Insulin/Type 1 Insulin-like Growth Factor Hybrid Receptors.

J. Menting, M. Lawrence, C. Ward, 2015, Structure.

A thermodynamic study of ligand binding to the first three domains of the human insulin receptor: relationship between the receptor alpha-chain C-terminal peptide and the site 1 insulin mimetic peptides.

J. Menting, M. Lawrence, C. Ward, 2009, Biochemistry.

Solution structure of ectodomains of the insulin receptor family: the ectodomain of the type 1 insulin-like growth factor receptor displays asymmetry of ligand binding accompanied by limited conformational change.

Brian J. Smith, J. Menting, J. Trewhella, 2009, Journal of molecular biology.

How ligand binds to the type 1 insulin-like growth factor receptor

J. Menting, M. Lawrence, V. Kiselyov, 2018, Nature Communications.

The signalling conformation of the insulin receptor ectodomain

C. Müller, J. Menting, T. Langer, 2018, Nature Communications.

How ligand binds to the type 1 insulin-like growth factor receptor

J. Menting, M. Lawrence, V. Kiselyov, 2018, Nature Communications.

Higher-Resolution Structure of the Human Insulin Receptor Ectodomain: Multi-Modal Inclusion of the Insert Domain.

Brian J. Smith, M. Lawrence, M. Weiss, 2016, Structure.

Case Report: Cytomegalovirus Disease Is an Under-Recognized Contributor to Morbidity and Mortality in Common Variable Immunodeficiency

J. Sasadeusz, J. Douglass, Lauren J. Howson, 2022, Frontiers in Immunology.

Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi.

R. Anders, S. Edwards, P. Crewther, 1998, Vaccine.

Insulin Mimetic Peptide Disrupts the Primary Binding Site of the Insulin Receptor*

Brian J. Smith, J. Menting, M. Lawrence, 2016, The Journal of Biological Chemistry.

How IGF-II Binds to the Human Type 1 Insulin-like Growth Factor Receptor

M. Lawrence, J. Sandow, B. Forbes, 2020, Structure.

Design of a candidate recombinant therapeutic vaccine for cervical cancer

S. Edwards, D. Hocking, M. Margetts, 1998 .

Antibody responses to HPV6b E polyproteins and production of monoclonal antibodies.

S. Edwards, M. Margetts, E. Webb, 2002, Hybridoma and hybridomics.

Leucine-zippered human insulin receptor ectodomain with single bound insulin - ""lower"" membrane-proximal part

C. Müller, J. Menting, T. Langer, 2018 .

Insulin Mimetic Peptide Disrupts the Primary Binding Site of the Insulin Receptor*

Brian J. Smith, J. Menting, M. Lawrence, 2016, The Journal of Biological Chemistry.